◼ Archived
Health
🔮 fades ✓
Flu season started earlier than expected
Flu season starts unexpectedly early, prompting health alerts and new vaccine availability.
Mrna
27 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Mrna
This hub groups 27 separate news trends connected to Mrna, spanning June 19, 2026 through October 15, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 250 article observations and 229 source signals, led by Health, Business coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Health
🔮 fades ✓
Cancer Vaccines Are the N.I.H.’s Next ‘Big Bet’
The NIH is staking $200 million on a public-private push to advance cancer vaccines across mRNA, peptide, and dark proteome technologies.
◼ Archived
Business
🔮 fades ✓
Cancer Vaccines Are the N.I.H.’s Next ‘Big Bet’
NIH to launch a cancer vaccine initiative
◼ Archived
Business
🔮 fades ✓
Moderna stock jumps on planned national cancer vaccine effort
Moderna stock jumps on planned national cancer vaccine effort
◼ Archived
Business
🔮 fades ✓
Novartis pens $7.8B deal for Abogen's in vivo autoimmune T-cell engager
A $7.8 billion Chinese biotech pact flips the script on Western pharma’s mRNA playbook.
◼ Archived
Health
🔮 fades ✓
Exclusive | She was ready to die. Now she’s in remission
A woman's remarkable recovery from cancer raises hopes for new vaccines.
◼ Archived
Health
🔮 fades ✓
Accelerated discovery of thermostable mRNA–lipid nanoparticle vaccines using data-efficient AI
Scientists discover AI-optimized mRNA vaccines that can withstand high temperatures without refrigeration.
◼ Archived
Health
🔮 fades ✓
‘Smart’ Nanoparticles Deliver mRNA Directly to Tumors in New Cancer Therapy
5 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Flu season is coming: What to know about new vaccine, when to get your shot and more
New mRNA flu vaccine approved for adults 50 and older.
◼ Archived
Health
🔮 fades ✓
What to know about the new mRNA flu vaccine
Moderna’s mRNA flu shot receives FDA clearance, promising broader immunity as flu season looms.
◼ Archived
Business
🔮 fades ✓
Personalized mRNA cancer vaccines offer new hope. We explain
Personalized mRNA cancer vaccines spark a biotech gold rush, drawing investors and reshaping oncology treatment.
◼ Archived
Business
🔮 holds ✗
GSK catches phase 3 fever after mRNA flu vaccine beats standard shots
GSK's mRNA flu vaccine is advancing to Phase 3 trials after outperforming standard shots in Phase 2.
◼ Archived
Business
BioNTech-Genentech cancer vax records more deaths than control in scrapped ph. 2 test
BioNTech and Roche have halted a mid-stage cancer vaccine trial after more deaths occurred in the treatment group than in the control group.
◼ Archived
Health
🔮 fades ✓
With mRNA back in the spotlight, tRNA shows potential to treat genetic disease
A new RNA therapy approach offers hope for genetic diseases that current drugs miss
◼ Archived
Business
🔮 fades ✓
Moderna, Merck breakthrough could usher in wave of cancer vaccines
A cancer vaccine breakthrough is stirring debate over profits and public health, as Moderna and Merck's stock prices surge.
◼ Archived
Health
🔮 fades ✓
Experimental Drug Generates Immune Response Against Pancreatic Cancer in People at High Risk
An experimental vaccine is generating immune responses against pancreatic cancer in high-risk individuals, according to early clinical findings.
◼ Archived
Business
🔮 fades ✓
Moderna Shares Double on Success of mRNA Cancer Vaccine
Moderna's shares have doubled since August 19th, 2026, as investors react to a breakthrough in cancer treatment.
◼ Archived
Business
Moderna surges as Merck-partnered melanoma vaccine cuts recurrence in large trial
Moderna's stock surges as a melanoma vaccine developed with Merck shows promise in a large trial
◼ Archived
Business
🔮 fades ✓
Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
Moderna's stock surged 160% after the company and Merck announced success in a late-stage melanoma vaccine trial
◼ Archived
Health
A new flu vaccine geared to older people is coming soon
The FDA has officially approved the first mRNA-based influenza vaccine, specifically designed to target the health needs of older Americans.
◼ Archived
Business
🔮 holds ✗
F.D.A. Approves Moderna’s mRNA Flu Vaccine
The FDA's approval of Moderna's mRNA flu vaccine marks a significant shift in seasonal flu prevention, particularly for older adults.
◼ Archived
Health
🔮 fades ✓
FDA approves 1st mRNA flu shot, from Moderna
The FDA has approved the first mRNA flu vaccine, marking a significant shift in flu shot technology.
◼ Archived
Health
🔮 fades ✓
Moderna begins Phase 1 clinical trial of Ebola vaccine against strain behind DRC outbreak
Moderna's Phase 1 Ebola vaccine trial begins as the outbreak in DR Congo continues to spread
◼ Archived
Health
🔮 fades ✗
Targeting Allele-Specific Faulty MRNA In SCNA2 Mutation Patients
8 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
An HIV vaccine is within reach thanks to mRNA
Recent breakthroughs in mRNA technology have brought an HIV vaccine closer to reality.
◼ Archived
Health
🔮 fades ✗
Only 13% survive this cancer. A blood test just detected 90% of early cases
A new blood gene test has demonstrated the ability to detect 90% of early-stage pancreatic cancers, a disease with a 13% survival rate.
◼ Archived
Business
🔮 fades ✓
New First-of-Its-Kind Flu Vaccine Approved by FDA Expert Panel
An FDA advisory panel has unanimously endorsed Moderna's first-of-its-kind mRNA-based seasonal influenza vaccine, mRNA-1010.